Japan's Taisho in lead to buy Paras Pharma

Japan's Taisho Pharmaceuticals has emerged the top bidder to buy a majority stake in Indian drugmaker Paras Pharmaceuticals, which owns popular brands such as anti-cold medication D'Cold and pain relieving ointment Moov, the Economic Times says. Report

Suggested Articles

Allergan was willing to part with candidate brazikumab to pass FTC muster, but union and consumer groups say that sale won't amend antitrust worries.

North Carolina is providing some financial assistance for the construction of Audentes gene therapy facility in Sanford, North Carolina. (Astellas)

BMS' Opdivo-Yervoy combo is playing in an increasingly crowded space. But the company is leaning on new long-term data to set its regimen apart.